Refine Results
- Products
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
The Agilent xCELLigence real-time cell analysis (RTCA) eSight system gives its users the flexibility to use both label-free impedance and/or imaging in four channels for the real-time monitoring of cell proliferation and cytotoxicity. The eSight has...
- Publication Part Number: 5994-8429EN
- Created: 22 Sep 2025
- 2 MB
Robust microplate-based approach for quantifying induced activation of T cells utilizing automated imaging, luminescence, and ELISA.
- Publication Part Number: 5994-8474EN
- Created: 04 Aug 2025
- 698 KB
Here we describe image-based immune cell killing assays of 3D single tumor spheroids expressing RFP using the xCELLigence RTCA eSight.
- Publication Part Number: 5994-8380EN
- Created: 14 July 2025
- 2 MB
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Publication Part Number: 5994-1303EN
- Created: 08 July 2025
- 6 MB
Describes use of a tethering approach to immobilize liquid tumor cell lines on to the surface of gold biosensors embedded in an Agilent E-Plate.
- Publication Part Number: 5994-1066EN
- Created: 27 June 2025
- 687 KB
The Agilent BioTek Cytation C10 confocal imaging reader provides a high-throughput kinetic 3D fluorescence microscopy solution to quantify CAR T-mediated cell killing of target spheroids.
- Publication Part Number: 5994-8428EN
- Created: 27 June 2025
- 3 MB
Automated brightfield imaging assay enables label-free quantification of T cell and CAR T cell activation through dynamic cluster formation analysis.
- Publication Part Number: 5994-8424EN
- Created: 27 June 2025
- 2 MB
This application note demonstrates a robust method for performing real-time antibody internalization assays using the Agilent xCELLigence RTCA eSight combined with CypHer5E pH-sensitive dyes.
- Publication Part Number: 5994-8106EN
- Created: 02 May 2025
- 4 MB
Discover Agilent's automated imaging-based method for robust analysis of CAR T cell cytotoxicity, enhancing cancer treatment efficacy and research efficiency.
- Publication Part Number: 5994-8228EN
- Created: 23 Apr 2025
- 2 MB
Agilent NovoCyte technical overview. Xdrop enables quick and easy encapsulation of cells and small molecules in double-emulsion droplets. Double-emulsion droplets are compatible with flow cytometry. Two types of fluorescent beads were...
- Publication Part Number: 5994-7876EN
- Created: 12 Nov 2024
- 1 MB
Research highlight confirming the critical role of metabolic fitness in CAR-NK cells and its importance to achieve superior clinical outcomes in immunotherapy.
- Publication Part Number: 5994-7661EN
- Created: 30 Aug 2024
- 313 KB
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
- Publication Part Number: 5994-7175EN
- Created: 06 June 2024
- 2 MB
A 45-color spectral flow cytometry panel was designed for the Agilent NovoCyte Opteon spectral flow cytometer to analyze the distribution of immune cells.
- Publication Part Number: 5994-7397EN
- Created: 30 May 2024
- 8 MB
| Korean (Korea) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
| Japanese (Japan) | Complete (PDF) |
This poster reveals to optimize T-cell differentiation in bioreactors using integrated Agilent cell analytics and feedback control to enhance CAR T-cell therapyproduction.
- Publication Part Number: Cyto 2025 #66
- Created: 05 June 2025
- 460 KB
CAR T-cell manufacturing conditions are critical to differentiation, metabolic fitness, and cytotoxic function, enhancing therapy efficacy and production efficiency.
- Publication Part Number: Cyto 2025
- Created: 05 June 2025
- 537 KB
Poster presented at AAI 2025. Immune cell-mediated cytotoxicity of CD19 CAR-T cells against Raji suspension tumor cells was monitored and measured using real-time whole-well live cellimaging on the xCELLigence RTCA eSight system with its 5x...
- Publication Part Number: AAI 2025 #3083
- Created: 14 May 2025
- 3 MB
In this study, we present a robust approach to monitor and analyze the bystander effect of Antibody-Drug Conjugates in real-time using live-cell imaging andimpedance measurements with the Agilent xCELLigence RTCA eSight system.
- Publication Part Number: AACR 2025 #5476
- Created: 25 Apr 2025
- 2 MB
AACR 2025 poster: Chronic anti-CD3/CD28 stimulation during cell expansion generates exhausted T cells with a distinct metabolic and cytotoxic phenotype
- Publication Part Number: AACR #4856
- Created: 25 Apr 2025
- 475 KB
AACR 2025 poster: Chronic anti-CD3/CD28 stimulation during cell expansion generates exhausted T cells with a distinct metabolic and cytotoxic phenotypeCAR T cells were tested against breast cancer cells (T47D) over seven rounds to assess...
- Publication Part Number: AACR 2025 Poster#4856
- Created: 25 Apr 2025
- 426 KB
There is a need for functional potency assays that can be used to rapidly test the efficacy of different immunotherapy approaches, including but not limited tosmall molecules, biologics, cell therapies, or combinations of these agents
- Publication Part Number: #91
- Created: 19 Mar 2025
- 2 MB